Sonermin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSonermin
Drug Alias NameRecombinant Human Tumour Necrosis FactorSertenefTNFTienefPT 050 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionTumor necrosis factor receptor agonists
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsSkin NeoplasmsBrain NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo Dainippon
Active IndicationsN/A
Inactive IndicationsSkin NeoplasmsBrain NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A